Does Fenbendazole Kill Cancer Cells? What the Research Actually Shows

In laboratory dishes, fenbendazole has shown the ability to kill some Cancer Cells. In animals, results have been mixed. In humans, there are no completed clinical trials proving it treats or cures cancer. Because of that gap, major cancer organizations do not recommend it as a treatment.

What is fenbendazole?

Fenbendazole is a Benzimidazole anthelmintic, a drug that treats parasitic worms in animals such as dogs, cats, horses, and livestock. It is approved for veterinary use in the United States. It is not an FDA-approved human medication.

Why is fenbendazole linked to cancer online?

Interest grew after social media posts and a book by Joe Tippens, who described using fenbendazole while also receiving an approved immunotherapy as part of a clinical trial for lung cancer. Because he was on proven treatment at the same time, his story cannot show that fenbendazole caused his result. As a result, one anecdote does not constitute scientific proof.

However, how might fenbendazole affect Cancer Cells?

Laboratory studies suggest several possible mechanisms:

• Moreover, microtubule disruption: Like some chemotherapy drugs, benzimidazoles can interfere with microtubules, the structures cells use to divide. As a result, cancer cells may stop dividing.
• Moreover, p53 activation: Some studies report activation of the p53 tumor-suppressor pathway, which can trigger cell death.
• Glucose metabolism: Research suggests it may reduce glucose uptake in Cancer Cells.
• Cell-cycle arrest: Studies report that treated cells stall at the G2/M phase.

These findings come from Cancer Cells cultures and a small number of animal experiments. Results in a dish often do not carry over to people.

What does the evidence show?

Fenbendazole vs. mebendazole vs. albendazole

Related benzimidazole drugs, especially mebendazole, have been studied more in human cancer research, including early trials in brain tumors. Mebendazole and albendazole are approved for humans (for parasites) and have human safety data, while fenbendazole does not. Research on one drug cannot be assumed to apply to another.

Is fenbendazole safe for humans?

Safety is the biggest unknown:

• It has no established human dose.
• Published case reports have linked its use to liver injury in people.
• Products sold for animals are not manufactured or tested to human-grade standards, so purity and dosing can vary.
• It could interact with chemotherapy, immunotherapy, or other medications.
• Delaying proven treatment to try an unproven one can allow cancer to progress.

Is it legal in the US?

Fenbendazole is legal to sell for veterinary use. Marketing it to treat cancer in humans is not permitted, and the FDA and FTC have acted against unapproved cancer claims. Always buy animal products only for animal use.

What should you do if you are considering it?

1. Talk to your oncologist first. Interactions and liver risk matter.
2. Ask about clinical trials at ClinicalTrials.gov or through the National Cancer Institute, which may offer access to promising investigation drugs under supervision.
3. Ask about drug-repurposing research, such as mebendazole trials.
4. Get a liver-function baseline if your doctor agrees to monitor you.
5. Never replace standard treatment with fenbendazole.

Frequently asked questions

Does fenbendazole cure Cancer Cells?
No. There is no clinical evidence that it cures cancer in humans.

Is the Joe Tippens protocol proven?
No. It is based on one person’s account and has not been validated in clinical trials.

Can fenbendazole be used with chemotherapy?
Unknown. Interactions have not been studied, so discuss it with your care team.

Is fenbendazole approved for humans?
No. It is approved only for veterinary use in the US.

What is the difference between fenbendazole and ivermectin?
Both are Anti parasitic drugs, but they work differently and are different chemicals. Neither is approved to treat Cancer Cells.

Are there human trials of related drugs?
Yes, mebendazole has been studied in early human trials, but fenbendazole has not.

Bottom line

Fenbendazole can kill some cancer cells in laboratory settings, but that does not mean it works in patients. Until human clinical trials exist, it remains unproven and potentially risky. The safest next step is a conversation with your oncology team about evidence-based options and clinical trials.